MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games

prescribing patterns

Search medical newsFind research, conditions and clinical updates
  • Home
  • prescribing patterns
住院出院时酒精使用障碍处方为何偏低?关键预测因素与干预切入点
Posted inClinical Updates Internal Medicine Psychiatry

Hospital Discharge Prescriptions for Alcohol Use Disorder: Unveiling Key Predictors to Bridge the Treatment Gap

Posted by By MedXY 11/01/2026
Despite proven benefits, medications for alcohol use disorder remain underprescribed at hospital discharge. This study identifies hospitalization and patient factors influencing new prescriptions, highlighting opportunities to enhance AUD treatment integration in inpatient settings.
Read More
Psychoactive Medication Prescribing After Critical Illness in American Adults Not Justified by a Documented Supporting Diagnosis
Posted inCritical Care news Psychiatry

Psychoactive Medication Prescribing After Critical Illness in American Adults Not Justified by a Documented Supporting Diagnosis

Posted by By MedXY 08/15/2026
Nearly half of psychoactive medications newly prescribed after ICU stays in American adults lack documented diagnostic justification, persisting for up to two years post-hospitalization.
Read More
Immunotherapy Prescribing Patterns and Immune-Related Adverse Events in Head and Neck Cancer
Posted innews Oncology Otorhinolaryngology

Immunotherapy Prescribing Patterns and Immune-Related Adverse Events in Head and Neck Cancer

Posted by By MedXY 04/27/2026
A large claims-based study reveals pembrolizumab dominates immunotherapy prescribing for head and neck cancer, with minimal usage growth since FDA approval. Immune-related adverse events occurred in 41.2% of patients, linked to specific comorbidities.
Read More
Money Talks: How Pharmaceutical Industry Payments Influence MS Doctors to Prescribe Costlier Brand-Name Drugs Over Generics
Posted inNeurology news Public Health

Money Talks: How Pharmaceutical Industry Payments Influence MS Doctors to Prescribe Costlier Brand-Name Drugs Over Generics

Posted by By MedXY 04/08/2026
A new study reveals that neurologists receiving $1,000 or more from drug manufacturers were over 4 times more likely to prescribe expensive brand-name MS medications when generics were available, driving up costs for patients and the healthcare system.
Read More
ADHD Drugmakers Double Marketing Spending to Clinicians: Implications for Prescribing and Patient Care
Posted inMedical News Neurology news Pediatrics Psychiatry Specialties

ADHD Drugmakers Double Marketing Spending to Clinicians: Implications for Prescribing and Patient Care

Posted by By MedXY 09/01/2025
Pharmaceutical companies have significantly increased marketing payments to clinicians for ADHD medications, particularly targeting advanced practice clinicians. The impact of this trend on prescribing patterns and clinical benefits remains to be fully understood.
Read More

Take a game break

Explore a few games from MedXY.

Explore all games
  • Targeting ANGPTL4 with MAR001: A Promising Approach for Reducing Elevated Triglycerides
  • Enhancing Muscle Endurance: The Impact of Superimposed Tendon Vibration on Isometric Knee Extension Fatigue
  • Enhancing Reactive Balance in Incomplete Spinal Cord Injury: Evaluating the Impact of Functional Electrical Stimulation Combined with Reactive Balance Training
  • Assessing Risks and Safety in Pediatric Dental Sedation: Insights from Claims Data Analysis (2014-2019)
  • Pathotype-Specific Gene Expression Illuminates Genetic Susceptibility in Early Rheumatoid Arthritis
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk case report chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation machine learning MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top